Subthreshold micropulse laser versus standard laser for the treatment of central-involving diabetic macular oedema with central retinal thickness of <400µ: a cost-effectiveness analysis from the DIAMONDS trial.

ABSTRACT:

Objectives

To estimate the economic costs, health-related quality-of-life outcomes and cost-effectiveness of subthreshold micropulse laser (SML) versus standard laser (SL) for the treatment of diabetic macular oedema (DMO) with central retinal thickness (CRT) of <400µ.

Design

An economic evaluation was conducted within a pragmatic, multicentre, randomised clinical trial, DIAbetic Macular Oedema aNd Diode Subthreshold.

Setting

18 UK Hospital Eye Services.

Participants

Adults with diabetes and centre involving DMO with CRT<400µ.

Interventions

Participants (n=266) were randomised 1:1 to receive SML or SL.

Methods

The base-case used an intention-to-treat approach conducted from a UK National Health Service (NHS) and personal social services (PSS) pers

SUBMITTER: Mistry H 

PROVIDER: S-EPMC10603454 | biostudies-literature | 2023 Oct

REPOSITORIES: biostudies-literature